Researchers noted that the safety and effectiveness of standard therapies for Merkel cell carcinoma “remains poorly studied.” ...

Researchers concluded that dabrafenib and trametinib appeared active in the second-line adjuvant setting, “although more follow up is required to confirm.” ...

The European MINDACT (Microarray In Node negative Disease may Avoid ChemoTherapy) trial will directly compare a gene-signature-based decision with an Adjuvant!-Online-based decision for cases in ...

At 12-year follow-up, C9741 confirmed the sustained long-term benefit of adjuvant dose-dense chemotherapy for node-positive breast cancer. SET2,3 identified patients with ER+ breast cancer who ...

3 All India Institute of Medical Sciences, New Delhi, India Purpose To evaluate the role of topical cyclosporine A 1% (CsA) as an adjuvant therapy in patients with acute Stevens-Johnson syndrome (SJS) ...

The change in policy at the health system follows the death of a DPD deficient patient and comes during a period of intense competition among Boston hospitals.

Commissions do not affect our editors' opinions or evaluations. Online learning can remove some of the barriers to traditional higher education, making it easier for busy students to earn a ...

A pooled analysis of studies assessing dose-dense adjuvant chemotherapy has shown that most of the therapeutic benefit derived from dose-dense scheduling arises in patients with node-positive ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: ...